Search

Doctors Zone

Journal (JEBH)

Alpha™- Liv Drops

Alpha – Liv Drops Due to high demand from the market, for a formulation in drops for the liver, apart from the syrup already available in the market, Schwabe India developed this product. Introduction The liver plays a key role in metabolism. It has anabolic and catabolic, exocrine and endocrine functions. The liver is a blood reservoir, filter and store of different substances (e.g. glycogen, vitamins). It is the site of serum protein (e.g. albumin, prothrombin, fibrinogen) and enzyme synthesis. Metabolic processes (e.g. bilirubin, hormone, carbohydrate and lipid turnover) and the removal of toxic products are important liver functions. 1 Hepatotoxins (e.g. alcohol, tetracycline, acetaminophen, fungal toxins, and anabolic steroids) can cause specific damage to liver cells. Toxic hepatitis may be clinically silent or severe enough to lead to the rapid development of hepatic failure. Clinical features include hepatomegaly, enzyme abnormalities, fever, abdominal pain, anorexia, nausea, vomiting and weight loss. In patients with underlying cirrhosis, manifestations of portal hypertension may predominate. Aversion to fatty food, abdominal discomfort, nausea and vomiting after meals may be symptoms of 2 cholelithiasis. Jaundice results from accumulation of bilirubin. It has non-hepatic as well as hepatic causes. Hyperbilirubinaemia may be due to abnormalities in the 3 formation, transport, metabolism or excretion of bilirubin. TM Alpha -Liv Drops aids recovery and normalisation of liver functions. Severe liver disease needs specialised treatment. Indications: Slow liver functions, fatty liver, and for supportive treatment of hepatocellular jaundice and toxic liver damage.

Read More »

Schwabe News Jan to June 2017 MoU Signing with Amity University

 

MoU Signing with Amity University

Schwabe India has signed MoU (Memorandum of Understanding) with Amity University (one of the top university of Asia) on 9th March 2017. This MoU was signed to explore and identify future researches in product development, safety profile, and efficacy evaluation. For the advancement of homoeopathy industry such scientific evaluations would be very essential & supportive. Scientific studies help consumers to get good quality products. MoU was signed by Mr. Ashish Kumar and Dr. W. Selvamurthy, President, Amity science and Technology, in the presence of Mr Peter Braun, Global Head of Homoeopathic Business, Schwabe Group, Ms. Julia Peterle, Area Manager of Affiliated Companies Woldwide, DHU, Dr. Ashok K Chauhan, Founder President, Amity Group, Dr. R.K.Manchanda, Director of CCRH, Dr. Rajeev Kr. Sharma, Director, Pharmacopoeia Commision for Indian Medicine and Homoeopathy, Ministry of AYUSH. 

Recent Advancements in Basic Homeopathic Research – A Report on Two Significant Publication

In a study conducted at the Experimental Farm of the State University of Santa Catarina, Brazil, researchers investigated the impact of homeopathic treatments on piglets during the nursery phase. The study aimed to determine whether homeopathic agents could reduce fighting behavior, improve growth performance, and affect hematological, metabolic, and oxidative variables. The study included 108 weaned piglets divided into four groups: a negative control group receiving only the basal diet, and three groups receiving different homeopathic treatments at varying dosages.

Read More »

Journal of Evidence Based Homeopathy
Volume: 1, Issue: 1, January - June 2023

Comprehensive articles

Short cases

Recent provings and updated materia medica

Materia medica on phytohomeopathy

Mother tincture

Product watch

Research News